Mr Javier Huarte > Grau & Angulo > Barcelona, Spain > Lawyer Profile

Grau & Angulo
C/ JOSEP IRLA I BOSCH 5-7
08034 BARCELONA
Spain

Work Department

Life Sciences

Position

Partner

Career

Javier joined Grau & Angulo in 2003 and has been a partner since 2005.

Javier leads the firm’s team for advice and litigation on pharmaceutical patents. He has formed an excellent portfolio of clients and for over twenty years he has acted in the most significant pharmaceutical patent cases in Spain.

Javier publishes regularly in international magazines specialised in Intellectual Property, particularly on litigation over pharmaceutical patents, and takes part in congresses and seminars on this theme.

Languages

Spanish, English, Catalan

Memberships

Member of the Barcelona Bar Association and AIPPI

Education

Master in Industrial and Intellectual Property from Alicante University (Magister Lvcentinvs).

Graduate in Law from Barcelona University.

Lawyer Rankings

Spain > Intellectual property: patents

(Hall of Fame)

Javier HuarteGrau & Angulo

Noted by a client as the best law firm in Spain for patent litigation matters’, Grau & Angulo excels in injunction proceedings, infringement matters and counterclaims involving pharmaceutical patents. The group is capable of handling contentious matters at the domestic and European levels, and acts for an expanding client roster featuring names from the life sciences, energy and telecoms sectors, among others. Patent litigator Javier Huarte, a key contact for pharma clients, and telecoms patent specialist Jesús Arribas co-lead the group alongside cross-border litigation authority Alejandro Angulo and Ignacio Pontijas, who concentrates on litigation involving the pharma sector. The firm also benefits from the aptitude of Ignacio Marqués, who focuses on cross-border litigation and licensing agreements. Ana-Laura Morales stands out for her expertise in mechanical and electronic patents, assisting companies with both contentious and non-contentious matters, while José Calvo is especially active in life sciences-related IP issues.